Search

You searched for "lesion"

2353 results found

Four key questions and answers for glaucoma practitioners

1 October 2018 | | EYE - Glaucoma
In this discussion paper the authors pose four questions for the clinician diagnosing and monitoring glaucoma, and supply evidence-based answers. Worldwide, the most common functional test used to diagnose and monitor glaucoma is static automated perimetry, most typically with a...

The Makassar-Dundee VISION 2020 LINK: a tale of two cities and two trainees

1 October 2014 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
A resident’s view from Makassar My name is Hendra Kusuma, a final year resident (registrar) in the ophthalmology department at Hasanuddin University in Makassar, Indonesia. We have had a VISION 2020 LINK with Dundee (coordinated at the UK end by...

The future of SLT?

2 February 2024 | | EYE - General, EYE - Glaucoma
For Feb/Mar 2024, we are looking at a recently released laser machine to perform direct SLT – selective laser trabeculoplasty (DSLT). Although SLT is well known, DSLT is sufficiently novel that a brief description is a good place to start....

NEOS (North Of England Ophthalmological Society) Spring Meeting 2024

23 April 2024
by Matthew Hartley, Trainee, Northern Deanery, UK. In NEOS’ 110th year, the spring meeting was held in Doncaster and centred around ocular oncology and vitreoretinal surgery. The meeting hosts, Umi Harley and Steve Winder from Royal Hallamshire Hospital, arranged a...

BELKIN Vision is pleased to announce FDA clearance for its glaucoma laser, the Eagle device

14 December 2023 | SLT, DSLT, the eagle, Belkin, Glaucoma, Laser therapy, USA
BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.

The Lily Foundation celebrates approval of first ever mitochondrial disease treatment by NICE

14 August 2025 | Leber’s hereditary optic neuropathy, idebenone, Pharmacology, new therapies, research
The Lily Foundation, the UK’s leading mitochondrial disease charity, is today celebrating a landmark achievement in the fight against the disease – the first ever treatment for a mitochondrial condition has been approved for use on the NHS in England....

Her Royal Highness The Duchess of Edinburgh awarded Honorary Fellowship of The College of Optometrists for her outstanding contribution to eye health

22 October 2025 | The College of Optometrists, eye health, award, public awareness, optometry
The College of Optometrists has presented Her Royal Highness The Duchess of Edinburgh with an Honorary Fellowship of the College in recognition of Her Royal Highness’s outstanding contribution to eye health. The Duchess is passionate about preventing avoidable sight loss...

Building Capacity for Children’s Eye Care in Africa: the VISION 2020 LINKS Programme

1 December 2013 | | EYE - Paediatrics, EYE - Strabismus, EYE - General
This article follows the Correspondent News articles in the previous five print issues of Eye News [1-5] on the VISION 2020 LINKS Programme [6]. This article describes how African and UK eye care teams are working together to tackle childhood...

Refraction planning in cataract: avoid creating an unhappy patient

1 June 2017 | | EYE - Cataract, EYE - Refractive
“It is much more important to know what sort of a patient has a disease than what sort of a disease a patient has.” William Osler The focus of this paper is the prevention of an unhappy patient following cataract...

The Escape Room and gamification of ophthalmology teaching

3 April 2024 | | EYE - General
Recently, there has been an interesting development in medical education and its ‘gamification’. Educators are constantly looking for new ways to engage their students by adding a friendly element of competition, as evidenced by the great success of online education...

Embracing assistive technology in the fight against sight loss

10 June 2020 | | EYE - General
The author shares his own experience of sight loss and explains the vital role assistive technology can play in the lives of visually impaired patients. There is no doubt that sight loss continues to be a clear and present danger,...

Aspiration of anteriorly migrated dexamethasone implant using an 18G intravenous cannula

4 December 2025 | | EYE - Cornea, EYE - Vitreo-Retinal
Intravitreal dexamethasone (Ozurdex 0.7mg) is a biodegradable, sustained-release implant used to manage diabetic macular oedema, macular oedema secondary to retinal vein occlusion, and non-infectious posterior uveitis due to its anti-inflammatory effects and VEGF suppression [1]. While effective, the implant may...